Revised criteria for the diagnosis and staging of Alzheimer’s disease

Clifford R. Jack, Scott J. Andrews, Thomas G. Beach, Teresa Buracchio, Billy Dunn, Ana Graf, Oskar Hansson, Carole Ho, William Jagust, Eric McDade, Jose Luis Molinuevo, Ozioma C. Okonkwo, Luca Pani, Michael S. Rafii, Philip Scheltens, Eric Siemers, Heather M. Snyder, Reisa Sperling, Charlotte E. Teunissen, Maria C. Carrillo

Research output: Contribution to journalDebate/Note/Editorialpeer-review

Abstract

Alzheimer’s disease can be treated by targeting amyloid-β plaques and diagnosed in vivo by biomarkers, prompting the revision of criteria for the diagnosis and staging of this disease.

Original languageEnglish
Pages (from-to)2121-2124
Number of pages4
JournalNature Medicine
Volume30
Issue number8
DOIs
Publication statusPublished - 2024 Aug

Subject classification (UKÄ)

  • Neurology

Fingerprint

Dive into the research topics of 'Revised criteria for the diagnosis and staging of Alzheimer’s disease'. Together they form a unique fingerprint.

Cite this